Noninvasive prediction of coronary artery disease progression by comparison of serial exercise electrocardiography and dipyridamole stress echocardiography

被引:0
作者
Olaf Rodriguez
Eugenio Picano
Silvio Fedele
Martha Morelos
Mario Marzilli
机构
[1] Instituto Mexicano de Seguridad Social,
[2] CNR,undefined
[3] Institute of Clinical Physiology,undefined
来源
The International Journal of Cardiovascular Imaging | 2002年 / 18卷
关键词
atherosclerosis; dipyridamole; echocardiography; stress;
D O I
暂无
中图分类号
学科分类号
摘要
Background: The possibility of noninvasive prediction of angiographically assessed coronary artery disease (CAD) progression by comparison of serial studies of exercise electrocardiography (EET) and dipyridamole stress echocardiography (DET) is not known. Aim: To assess the relative value of EET and DET in predicting angiographically assessed progression of CAD. Methods: From the Institute of Clinical Physiology, National Research Council, Pisa Italy stress echo data bank (1983–1998), we selected 46 patients with two repeated EET, DET and coronary angiography (CA) in two different hospital admissions (46 ± 30 months). A priori, angiographic progressors were defined as any stenosis progression to occlusion and/or any stenosis > 30% with > 20% stenosis progression measured by visual and quantitative CA. EET progressors were defined as a previous negative test becoming positive or as a positive test with decrease in ischemic threshold response in the second test. DET progressors were defined as previous negative test becoming positive or as a positive test with a more severe ischemic response in the second test. Results: Angiographic progressors were 31/46 patients (67%) and angiographic nonprogressors were 15/46 (33%). When angiography was taken as the gold standard, there were no differences in sensitivity for EET and DET (87 vs. 87%). Specificity was significantly higher for DET (93 vs. 40% p =< 0.001). By κ statistics DET had a good concordance (κ = 0.768) and EET a poor concordance (κ = 0.299) with angiographic progression. Conclusion: DET is more accurate than EET at predicting angiographically assessed CAD progression.
引用
收藏
页码:93 / 99
页数:6
相关论文
共 133 条
[1]  
De Feyter PJ(1991)Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis: value, limitations, and implications for clinical trials Circulation 84 412-423
[2]  
Serruys PW(1993)Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis: implications for clinical trials Circulation 87 II38-II47
[3]  
Davies MJ(1995)Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification JAMA 274 894-901
[4]  
Richardson P(1994)Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium Circulation 89 1530-1538
[5]  
Lubsen J(1992)Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet J Am Coll Cardiol 19 34-42
[6]  
Oliver MF.(1995)Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease Am J Cardiol 76 122A-125A
[7]  
Waters D(1995)Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve Circulation 92 197-204
[8]  
Lespérance K(1999)Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound Circulation 100 509-515
[9]  
Craven TE(1998)Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography J Heart Lung Transplant 17 259-267
[10]  
Hudon G(2001)Non-invasive prediction of angiographic progression of coronary artery disease by dipyridamole stress echocardiography Coronary Artery Disease 12 197-204